Sam Brusco, Associate Editor05.11.23
Samsung has gained U.S. Food and Drug Administration (FDA) clearance for the Irregular Heart Rhythm Notification (IHRN) feature on its Samsung Health Monitor app.
Combined with the app’s existing on-demand electrocardiogram (ECG) function, the IHRN feature proactively monitors heart rhythms that suggest atrial fibrillation (AFib) from their wrist.
“We’re excited to announce that Irregular Heart Rhythm Notification, designed to help millions of people around the world who may not be aware of a potential heart risk, has been cleared by the FDA,” Hon Pak, VP and head of the Digital Health team, MX Business at Samsung Electronics told the press. “This is yet another example of how Samsung prioritizes proactive safety solutions and enables users to receive a more holistic understanding of their cardiovascular and overall health.”
Galaxy Watch utilizes Samsung’s BioActive sensor, which touts on-demand ECG recording and HR Alert function to spot abnormally high or low heart rates. Adding the new IHRN feature means Galaxy Watch users can monitor another aspect of their health.
Once activated in Samsung’s Health Monitor app, the feature checks for irregular heart rhythms in the background via the BioActive sensor. If a certain number of consecutive measurement come up irregular, Galaxy Watch informs the user of potential AFib. They are then prompted to take an ECG measurement using the watch for more accurate assessment.
Combined with the app’s existing on-demand electrocardiogram (ECG) function, the IHRN feature proactively monitors heart rhythms that suggest atrial fibrillation (AFib) from their wrist.
“We’re excited to announce that Irregular Heart Rhythm Notification, designed to help millions of people around the world who may not be aware of a potential heart risk, has been cleared by the FDA,” Hon Pak, VP and head of the Digital Health team, MX Business at Samsung Electronics told the press. “This is yet another example of how Samsung prioritizes proactive safety solutions and enables users to receive a more holistic understanding of their cardiovascular and overall health.”
Galaxy Watch utilizes Samsung’s BioActive sensor, which touts on-demand ECG recording and HR Alert function to spot abnormally high or low heart rates. Adding the new IHRN feature means Galaxy Watch users can monitor another aspect of their health.
Once activated in Samsung’s Health Monitor app, the feature checks for irregular heart rhythms in the background via the BioActive sensor. If a certain number of consecutive measurement come up irregular, Galaxy Watch informs the user of potential AFib. They are then prompted to take an ECG measurement using the watch for more accurate assessment.